Synthace, the platform that is allowing engineering to intersect with biology, has raised a £7.3M Series B round from investors that include Bioeconomy Capital, SOSV, Eleven Two Capital, Sofinnova Partners, Amadeus Capital Partners, and White Cloud Capital. The company founded in 2011 by Sean Ward has now raised a total of £12.28M over four rounds.
Page 10 of 11